Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4
- PMID: 27217734
- PMCID: PMC4862759
- DOI: 10.2147/CIA.S104599
Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4
Abstract
Background: Vitamin D levels play a pivotal role in most biological processes and differ according to age. A deficiency of vitamin D in chronic hepatitis C (CHC) patients has been shown to be linked with the severity of liver fibrosis, but little is known about the mechanism of this association.
Objective: In this study, we evaluate the potential interrelation between vitamin D levels, oxidative stress, and apoptosis, based on liver fibrosis in geriatric patients infected with hepatitis C virus (HCV) genotype 4.
Subjects and methods: A total of 120 adult individuals aged 30-68 years were recruited in this study. Of these, 20 healthy subjects (15 men and five women) with a mean age of 48.3±6.1 years were selected as controls, and 100 patients with a mean age of 47.8±4.9 years with chronic HCV (CHC) who had undergone liver biopsy (80 men and 20 women) were included in this study. Based on liver radiographic (computed tomography, magnetic resonance imaging) and histological Metavir system analyses, the CHC patients were classified into three groups: asymptomatic CHC carriers (n=30), fibrosis (n=25), and cirrhosis (n=45). HCV RNA, HCV genotypes, inflammatory cytokines AFP and TNFα, 25-hydroxyvitamin D (25[OH]D) levels, apoptotic markers single-stranded DNA (ssDNA) and soluble Fas (sFas), and oxidative stress markers nitric oxide (NO) and total antioxidant capacity (TAC) were estimated by using molecular, immunoassay, and colorimetric techniques.
Results: Approximately 30% of the study population (n=30) were diagnosed as asymptomatic CHC carriers, and 70% of the study population (n=70) had severe fibrosis; these were classified into fibrosis and cirrhosis. There was a significant reduction in 25(OH)D levels and TAC activity, along with an increase in levels of NO, AFP, TNFα, ssDNA, and sFas in fibrosis and cirrhosis subjects compared with those of asymptomatic CHC carriers and health controls. The deficiency in 25(OH)D levels correlated positively with sFas, ssDNA, AFP, TNFα, NO, and TAC, and negatively with age, sex, liver function, body mass index, homeostatic model assessment - insulin resistance, HCV RNA, and viral load. Significant intercorrelation was reported between serum 25(OH)D concentrations and apoptotic and oxidative markers, which suggested progression of liver pathogenesis and fibrogenesis via oxidative and apoptotic mechanisms.
Conclusion: The data showed that vitamin D status was significantly correlated with pathogenesis and fibrogenesis of the liver in geriatric patients infected with HCV genotype 4. The deficiency in 25(OH)D levels was shown to have a pivotal role in the pathogenesis of liver via apoptotic, oxidative stress, and inflammatory mechanistic pathways. The data point to adequate vitamin D levels being recommended for a good response to treatment strategies, especially in older CHC patients.
Keywords: 25(OH)D; Fas antigen; HCV; apoptosis; geriatrics; liver fibrosis; oxidative stress.
Figures
Similar articles
-
Handgrip Strength and Vitamin D as Predictors of Liver Fibrosis and Malnutrition in Chronic Hepatitis C Patients.Dis Markers. 2021 Apr 2;2021:6665893. doi: 10.1155/2021/6665893. eCollection 2021. Dis Markers. 2021. PMID: 33884041 Free PMC article.
-
Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.Ann Hepatol. 2013 Mar-Apr;12(2):199-204. Ann Hepatol. 2013. PMID: 23396730
-
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.Hepatology. 2010 Apr;51(4):1158-67. doi: 10.1002/hep.23489. Hepatology. 2010. PMID: 20162613
-
New insight of vitamin D in chronic liver diseases.Hepatobiliary Pancreat Dis Int. 2014 Dec;13(6):580-5. doi: 10.1016/s1499-3872(14)60295-2. Hepatobiliary Pancreat Dis Int. 2014. PMID: 25475859 Review.
-
Decreased circulating vitamin D reflects adverse outcomes of hepatitis C virus infection: A systematic review and meta-analysis.J Infect. 2020 Oct;81(4):585-599. doi: 10.1016/j.jinf.2020.06.025. Epub 2020 Jun 15. J Infect. 2020. PMID: 32553842
Cited by
-
Controversial Effects of Vitamin D and Related Genes on Viral Infections, Pathogenesis, and Treatment Outcomes.Nutrients. 2020 Mar 30;12(4):962. doi: 10.3390/nu12040962. Nutrients. 2020. PMID: 32235600 Free PMC article. Review.
-
Targeting Hepatic Fibrosis in Autoimmune Hepatitis.Dig Dis Sci. 2016 Nov;61(11):3118-3139. doi: 10.1007/s10620-016-4254-7. Epub 2016 Jul 19. Dig Dis Sci. 2016. PMID: 27435327 Review.
-
Correlations of Serum Vitamin D Level with Markers of Oxidative Stress and Apoptosis in Liver Cirrhosis.Curr Health Sci J. 2023 Jan-Mar;49(1):54-66. doi: 10.12865/CHSJ.49.01.54. Epub 2023 Mar 31. Curr Health Sci J. 2023. PMID: 37780191 Free PMC article.
-
Circulating microRNAs as potential biomarkers of physical activity in geriatric patients with HCV.BMC Mol Cell Biol. 2024 Jul 19;25(1):18. doi: 10.1186/s12860-024-00514-8. BMC Mol Cell Biol. 2024. PMID: 39030480 Free PMC article.
-
Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.Dig Dis Sci. 2019 Feb;64(2):324-344. doi: 10.1007/s10620-018-5351-6. Epub 2018 Oct 28. Dig Dis Sci. 2019. PMID: 30370494 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous